FASTEP Trademark

Trademark Overview


On Tuesday, October 3, 2023, a trademark application was filed for FASTEP with the United States Patent and Trademark Office. The USPTO has given the FASTEP trademark a serial number of 98208214. The federal status of this trademark filing is OPPOSITION PENDING as of Wednesday, October 30, 2024. This trademark is owned by Azure Biotech, Inc.. The FASTEP trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious diseases, tropical diseases, and sexually transmitted diseases; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of tumors, cardiac disease, and drugs; In-vitro ovulation prediction test kit for home use; In vitro gender prediction test kit; Ovulation test kits; Pregnancy test kits for home use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids
fastep

General Information


Serial Number98208214
Word MarkFASTEP
Filing DateTuesday, October 3, 2023
Status774 - OPPOSITION PENDING
Status DateWednesday, October 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 2, 2024

Trademark Statements


Description of MarkThe mark consists of a first droplet shaped element with a second droplet shaped element behind the first and partially blocked by the first, next to "FASTEP" with "STEP" underlined.
Goods and ServicesDiagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious diseases, tropical diseases, and sexually transmitted diseases; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of tumors, cardiac disease, and drugs; In-vitro ovulation prediction test kit for home use; In vitro gender prediction test kit; Ovulation test kits; Pregnancy test kits for home use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 3, 2023
Primary Code005
First Use Anywhere DateMonday, August 13, 2018
First Use In Commerce DateMonday, August 13, 2018

Trademark Owner History


Party NameAzure Biotech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHouston, TX 77025

Party NameAzure Biotech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77025

Trademark Events


Event DateEvent Description
Tuesday, October 3, 2023NEW APPLICATION ENTERED
Wednesday, December 20, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, December 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 23, 2024ASSIGNED TO EXAMINER
Wednesday, May 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 12, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 30, 2024EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, October 30, 2024OPPOSITION INSTITUTED NO. 999999
Wednesday, October 30, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED